Glycemic Metrics and Patterns in People With and Without Prediabetes
ConditionPre Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbbott Diabetes Care
About this trial
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Subject must be at least 18 years of age.
Subject must be willing and able to provide written signed and dated informed consent.
Disqualifiers
Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
Subject is known to be pregnant at the time of enrollment.
Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
Trial population
Subjects will be stratified into groups, including male and female sex, race, age and Body Mass Index. Approximately 25 evaluable subjects will be enrolled into each group.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
FreeStyle Libre 3
DeviceAbbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Characterize the glycemic profiles of people with and without a prediabetes diagnosis.
This is a data collection study.
Time frame
up to 50 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov